Old National Bancorp’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.8M Buy
126,179
+3,286
+3% +$707K 0.63% 25
2026
Q1
$26.7M Sell
122,893
-1,060
-0.9% -$235K 0.45% 35
2025
Q4
$28.3M Sell
123,953
-5,878
-5% -$1.34M 0.47% 32
2025
Q3
$30.1M Buy
129,831
+1,285
+1% +$262K 0.51% 27
2025
Q2
$23.9M Sell
128,546
-1,017
-0.8% -$189K 0.42% 36
2025
Q1
$27.1M Sell
129,563
-4,685
-3% -$911K 0.71% 22
2024
Q4
$23.9M Sell
134,248
-8,609
-6% -$1.58M 0.57% 31
2024
Q3
$28.2M Sell
142,857
-604
-0.4% -$113K 0.65% 26
2024
Q2
$24.6M Sell
143,461
-17,035
-11% -$2.82M 0.58% 28
2024
Q1
$29.2M Sell
160,496
-9,645
-6% -$1.66M 0.69% 26
2023
Q4
$26.4M Sell
170,141
-13,834
-8% -$2.02M 0.69% 27
2023
Q3
$27.4M Sell
183,975
-2,225
-1% -$327K 0.79% 20
2023
Q2
$25.1M Sell
186,200
-6,703
-3% -$983K 0.72% 21
2023
Q1
$30.7M Sell
192,903
-2,455
-1% -$375K 0.94% 16
2022
Q4
$31.6M Buy
195,358
+1,838
+0.9% +$282K 0.99% 15
2022
Q3
$26M Buy
193,520
+3,677
+2% +$528K 0.88% 18
2022
Q2
$29.1M Buy
189,843
+61,518
+48% +$9.4M 0.98% 14
2022
Q1
$20.8M Buy
128,325
+6,787
+6% +$986K 0.77% 30
2021
Q4
$16.5M Sell
121,538
-4,765
-4% -$563K 0.59% 39
2021
Q3
$13.6M Buy
126,303
+4,187
+3% +$478K 0.51% 52
2021
Q2
$13.8M Sell
122,116
-2,763
-2% -$311K 0.51% 52
2021
Q1
$13.5M Buy
124,879
+3,519
+3% +$376K 0.54% 47
2020
Q4
$13M Buy
121,360
+14,916
+14% +$1.43M 0.55% 47
2020
Q3
$9.32M Buy
106,444
+14,212
+15% +$1.34M 0.45% 60
2020
Q2
$9.06M Buy
92,232
+959
+1% +$84.4K 0.46% 56
2020
Q1
$6.95M Sell
91,273
-3,895
-4% -$332K 0.43% 64
2019
Q4
$8.43M Sell
95,168
-66,113
-41% -$5.49M 0.41% 65
2019
Q3
$12.2M Sell
161,281
-2,120
-1% -$145K 0.62% 44
2019
Q2
$11.9M Buy
163,401
+937
+0.6% +$73.6K 0.6% 42
2019
Q1
$13.1M Sell
162,464
-644
-0.4% -$52.7K 0.68% 38
2018
Q4
$15M Sell
163,108
-3,723
-2% -$327K 0.83% 27
2018
Q3
$15.8M Sell
166,831
-2,218
-1% -$210K 0.78% 26
2018
Q2
$15.7M Sell
169,049
-1,178
-0.7% -$115K 0.81% 27
2018
Q1
$16.1M Sell
170,227
-93,206
-35% -$10.2M 0.85% 26
2017
Q4
$25.5M Sell
263,433
-408
-0.2% -$38.5K 1.32% 15
2017
Q3
$23.4M Buy
263,841
+1,613
+0.6% +$123K 1.27% 15
2017
Q2
$19M Sell
262,228
-268
-0.1% -$18K 1.04% 19
2017
Q1
$17.1M Buy
262,496
+196
+0.1% +$12.3K 0.94% 22
2016
Q4
$16.4M Sell
262,300
-1,835
-0.7% -$112K 0.94% 27
2016
Q3
$16.7M Sell
264,135
-3,230
-1% -$209K 0.95% 31
2016
Q2
$16.6M Sell
267,365
-44,327
-14% -$2.7M 0.94% 30
2016
Q1
$17.8M Buy
311,692
+155,192
+99% +$8.65M 1.05% 23
2015
Q4
$9.27M Sell
156,500
-4,849
-3% -$279K 0.55% 55
2015
Q3
$8.78M Sell
161,349
-11,674
-7% -$760K 0.53% 58
2015
Q2
$11.6M Sell
173,023
-12,971
-7% -$847K 0.65% 48
2015
Q1
$10.9M Sell
185,994
-1,996
-1% -$121K 0.59% 52
2014
Q4
$12.3M Sell
187,990
-4,599
-2% -$290K 0.78% 42
2014
Q3
$11.1M Buy
192,589
+91,288
+90% +$5.07M 0.73% 46
2014
Q2
$5.72M Sell
101,301
-218,660
-68% -$11.5M 0.43% 59
2014
Q1
$16.4M Sell
319,961
-41,434
-11% -$2.09M 1.51% 19
2013
Q4
$19.1M Sell
361,395
-3,203
-0.9% -$157K 1.75% 20
2013
Q3
$16.3M Sell
364,598
-1,704
-0.5% -$75.5K 1.68% 22
2013
Q2
$15.1M Buy
+366,302
New +$16M 1.6% 24

Other funds holding ABBV

Old National Bancorp's ABBV Position: Q2 2026 in Review

Old National Bancorp increased its AbbVie (ABBV) stake by 2.7% in Q2 2026, buying an estimated $707K and bringing the position to 126,179 shares worth $31.8M. The position accounts for 0.63% of the portfolio, ranked #25.

Old National Bancorp first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Old National Bancorp held 126,179 shares of AbbVie worth $31.8M as of Q2 2026.
  • Old National Bancorp bought 3,286 AbbVie shares in Q2 2026, an estimated $707K.
  • AbbVie made up 0.63% of Old National Bancorp's portfolio in Q2 2026, its #25 holding.
  • Old National Bancorp first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Old National Bancorp's 13F filing for Q2 2026, filed 15 Jul 2026.